Anterior uveitis is inflammation of the front part of the eye, specifically the iris and the area just behind it called the ciliary body. It’s the most common form of uveitis and causes a red, painful eye with sensitivity to light and blurred vision. In the United States, uveitis overall affects about 19 per 100,000 people each year, and anterior uveitis accounts for the largest share of those cases.
What Happens Inside the Eye
The uvea is the middle layer of the eye wall, and it’s divided into three zones. The front zone contains the iris (the colored ring that controls your pupil size) and the ciliary body (a ring of muscle behind the iris that helps focus your lens). When these structures become inflamed, white blood cells and proteins leak into the fluid-filled space behind the cornea, called the anterior chamber. This flood of inflammatory debris is what causes the hallmark symptoms.
In more severe or prolonged cases, the inflamed iris can stick to the lens sitting just behind it, forming adhesions called posterior synechiae. When this happens, the pupil may look smaller than the other eye’s pupil or take on an irregular, non-circular shape. These adhesions can block the normal flow of fluid inside the eye and raise eye pressure if left untreated.
Symptoms to Recognize
Anterior uveitis typically comes on quickly over a day or two. The core symptoms are eye pain, redness concentrated in a ring around the colored part of the eye (sometimes called a ciliary flush), sensitivity to light, and blurry vision. The pain and light sensitivity are largely driven by spasm of the ciliary muscle, which contracts involuntarily in response to inflammation.
Most acute episodes affect one eye, though both eyes can be involved, particularly when the cause is autoimmune. The redness in anterior uveitis looks different from pink eye: instead of a general pinkness across the white of the eye, you’ll often notice a deeper, violet-tinged ring hugging the edge of the iris.
Common Causes and Triggers
In many cases, no specific cause is ever identified. When a cause is found, it falls into two broad categories: autoimmune conditions and infections.
The strongest autoimmune link is with a genetic marker called HLA-B27. In one study of 143 patients with HLA-B27-associated uveitis, 58% had an underlying systemic inflammatory disease, most commonly a type of spinal arthritis called ankylosing spondylitis. About 30% also had a family history of similar spinal or joint conditions. Inflammatory bowel disease and reactive arthritis are other associated conditions. Notably, in roughly half of those patients, the systemic disease was first discovered because they came in for an eye problem, meaning the uveitis was their first clue that something broader was going on.
Infectious triggers include herpes simplex virus, shingles (varicella-zoster virus), syphilis, tuberculosis, and toxoplasmosis. Cat-scratch disease, caused by a bacterial infection from cat scratches or bites, is another recognized trigger.
How It’s Diagnosed
An eye doctor examines the front of the eye using a slit lamp, a microscope with a narrow beam of light that illuminates the anterior chamber. The key findings are individual white blood cells floating in the chamber fluid (called “cells”) and a hazy glow from leaked proteins (called “flare”). These are graded on a standardized scale from 0 to 4+. A grade of 1+ means 6 to 15 cells are visible in the light beam, while 4+ means more than 50 cells, with intense haziness that obscures the details of the iris and lens.
If the inflammation keeps coming back or affects both eyes, your doctor will likely order blood work to look for autoimmune markers like HLA-B27, signs of infection such as syphilis or tuberculosis, and other inflammatory conditions. A chest X-ray may be part of the workup to rule out sarcoidosis or TB.
Treatment and What to Expect
The backbone of treatment is steroid eye drops, which reduce inflammation inside the eye. Prednisolone acetate 1% is the most widely used because it penetrates the cornea far better than other steroid drops, even though it’s technically less potent drop-for-drop. During a severe flare, you may be asked to use drops as often as every one to two hours, then gradually taper over several weeks as inflammation improves. A newer option, difluprednate 0.05%, achieves similar results with fewer daily doses (four times a day compared to eight).
Alongside steroids, you’ll typically be given dilating drops called cycloplegics. These serve three purposes: they relax the ciliary muscle spasm that’s causing much of the pain and light sensitivity, they keep the pupil mobile so the iris doesn’t stick to the lens, and they help stabilize the barrier between blood vessels and eye fluid to reduce further protein leakage. The dilating effect means your near vision will be blurry and light will feel brighter while you’re using them, but this is temporary.
Most acute episodes resolve within a few weeks with proper treatment. In the study that defined remission as inflammation-free within 90 days, all included patients achieved that initial remission.
Recurrence Rates
One of the frustrating realities of anterior uveitis is that it often comes back. In a study tracking patients after their first episode, 39% experienced a recurrence within about a year and a half. The relapse rate worked out to roughly 24% per person-year, meaning that for every year you go after remission, there’s about a one-in-four chance of another flare. At the 1.5-year mark, 61% of patients were still in remission.
Recurrence is more common in people who carry the HLA-B27 marker or have an underlying autoimmune condition. Recognizing the early signs of a flare, particularly mild pain, light sensitivity, or a slight haze in vision, and starting treatment quickly can shorten episodes and reduce the risk of complications.
Potential Complications
Cataracts are the most common long-term complication. Between 50% and 78% of eyes with uveitis eventually develop cataracts, with an annual incidence of 5% to 6%. The inflammation itself damages the lens over time, and the steroid drops used to treat the inflammation also promote cataract formation, creating a difficult trade-off. When cataract surgery is eventually needed, it’s more complex in uveitis patients because of challenges like a small pupil, iris adhesions, and a higher risk of postoperative inflammation and swelling in the central retina.
Elevated eye pressure is another concern. Inflammation can clog the eye’s drainage system, and steroid drops can independently raise pressure in some people. Prolonged high pressure can damage the optic nerve, leading to glaucoma. Regular pressure checks during and after treatment help catch this early. Swelling of the macula, the part of the retina responsible for sharp central vision, can also occur and is a leading cause of vision loss when it does.